FDA Inspection 1287796 — BioLyte Laboratories, LLC

BioLyte Laboratories, LLC — FEI 3013171766

The FDA completed an inspection of BioLyte Laboratories, LLC on Sep 12, 2025 in Grand Rapids, MI. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Sep 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Rapids, MI (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.